WMSA
ABMD

Weiss Multi-Strategy Advisers’s Abiomed Inc ABMD Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-5,000
Closed -$843K – 690
2017
Q3 		$843K Buy
+5,000
New +$756K 0.03% 392
2016
Q4 		– Sell
-5,000
Closed -$643K – 540
2016
Q3 		$643K Buy
+5,000
New +$599K 0.04% 326
2013
Q4 		– Sell
-20,000
Closed -$381K – 1151
2013
Q3 		$381K Buy
+20,000
New +$457K 0.01% 635

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $14.7B AUM 42.39% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $65.2B AUM 31.44% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Weiss Multi-Strategy Advisers's ABMD Position: Q4 2022 in Review

Weiss Multi-Strategy Advisers sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 13,900 shares — an estimated $3.42M sold.

Weiss Multi-Strategy Advisers first reported a position in ABMD in Q2 2013 and held it in 38 quarters. The position peaked at $8.54M in Q3 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Weiss Multi-Strategy Advisers reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 13,900 Abiomed Inc shares in Q4 2022, an estimated $3.42M.
  • Weiss Multi-Strategy Advisers first reported a position in Abiomed Inc in Q2 2013 and held it in 38 quarters.
  • Weiss Multi-Strategy Advisers's Abiomed Inc position peaked at $8.54M in Q3 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.